EP0443231A1 - Dispositif multicouche pour tests de diagnostic en vue de la détermination de substances dans des liquides - Google Patents

Dispositif multicouche pour tests de diagnostic en vue de la détermination de substances dans des liquides Download PDF

Info

Publication number
EP0443231A1
EP0443231A1 EP90301907A EP90301907A EP0443231A1 EP 0443231 A1 EP0443231 A1 EP 0443231A1 EP 90301907 A EP90301907 A EP 90301907A EP 90301907 A EP90301907 A EP 90301907A EP 0443231 A1 EP0443231 A1 EP 0443231A1
Authority
EP
European Patent Office
Prior art keywords
sample
site
reaction site
liquid
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP90301907A
Other languages
German (de)
English (en)
Other versions
EP0443231B1 (fr
Inventor
Raymond E. Kuhn
Gene H. Macdonald
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EDITEK, INC.
Original Assignee
Editek Inc
Environmental Diagnostics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to CA002010569A priority Critical patent/CA2010569A1/fr
Application filed by Editek Inc, Environmental Diagnostics Inc filed Critical Editek Inc
Priority to DE1990623476 priority patent/DE69023476T2/de
Priority to ES90301907T priority patent/ES2081924T3/es
Priority to EP19900301907 priority patent/EP0443231B1/fr
Publication of EP0443231A1 publication Critical patent/EP0443231A1/fr
Application granted granted Critical
Publication of EP0443231B1 publication Critical patent/EP0443231B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G01N33/525—Multi-layer analytical elements

Definitions

  • This invention relates to a diagnostic test device for determining the presence of substances in liquid media. More specifically, it relates to the provision of a multi-layered test device for determining the presence of immunological, biological, enzymatic materials or other analytes in liquids especially biological, industrial or agricultural liquids. Still more specifically, it relates to the provision of a multi-layered device for the detection of such substances in a rapid manner and wherein the results thereof are determinable without a reading instrument.
  • the art has evolved from the use of complex radioimmunoassays and enzyme immunoassays to the use of single card-type devices.
  • the art has sought to both increase the readability of such devices to eliminate the need for an instrument and to render the device readable in a shorter period of time so that one may make a determination of the analyte under field condition.
  • the art has also attempted to shorten the number of steps that are required to conduct the test so that elements of simplicity and convenience are introduced into the test system.
  • test device which is portable, develops a visual color change almost immediately upon the introduction of test sample, and is readable by the naked eye in a remote location without the need for instrumentation.
  • the art would benefit from a system which eliminates the need for multiple steps in performing the test and specifically, from the elimination of multiple wash steps and long incubation times so that the time for reading the test could be shortened and the convenience could be amplified dramatically.
  • test device having multi-layers and comprised of filter type planar membranes which incorporate therein binding materials at appropriate sites such as antibodies and/or antigens to facilitate the reaction mechanism.
  • the invention provides a composite structure of porous materials wherein, through the selection of different pore sizes in appropriate areas of the structure and the juxtaposition of liquid barrier means, a liquid flow path is defined which results in an unexpected liquid flow force sufficient to cause a discernible change in an immunologic complex or in other reactions when appropriate materials are selected.
  • a commonly encountered problem in the field of immunoassay occurs when competitive or sandwich type binding assays are performed on a solid porous matrix.
  • the immunological reaction in such procedures often does not occur rapidly enough nor conveniently visibly enough in the absence of several wash steps or reagent additions. Even with the additional steps, often times the reaction is not sufficiently visible within a convenient time to be useful.
  • an externally supplied tagged antigen competes with the antigen of a sample to react with an externally supplied antibody.
  • the analyte is an antibody, the appropriate binding partners are chosen.
  • Each antigen molecule whether tagged or present in the sample has an opportunity to react with the supplied antibody and the extent to which they do react is a measure of the concentration of the antigen in the original sample.
  • Applicant has discovered a structure and technique which favors in a simple one step operation the displacement of tagged antigen from a tagged antigen/antibody complex by sample antigen (if the complex is originally configured and supplied in this manner) or the effective competition between the sample analyte and externally supplied tagged analyte for the immobilized capture binding partner with rapid revelation of a visual indication of such reaction.
  • immunoassay formats such as sandwich reactions and competitive binding using a detection system for antibodies as the analyte rather than antigens as described, may also be employed as will be seen in the detailed description of the invention.
  • a structure is provided with a combination of various pore sizes and liquid flow barriers so as to produce rapid wicking of a sample in a pre-determined liquid flow direction to a reaction site at which the desired reaction takes place.
  • the present invention contemplates a structure having at least two planar, flat porous members in intimate contact with each other at their planar surfaces.
  • the multi-layered device is configured in such a way that when a small amount, such as a drop or two, of a liquid test sample is placed onto or into a sample receiving site provided at the top member, the liquid is forced to travel transversely into the bottom member owing to the presence of liquid flow barriers placed or created adjacent to the sample receiving site.
  • the sample receiving site may be a hole in the top member, or may be the top member itself appropriately shaped or confined in consideration of the type of test to be performed.
  • the device is configured in such a way as to force the flow sample liquid from the sample receiving port or site along a pre-determined pathway to the bottom member and ultimately to a reaction site on the bottom or top member depending upon the pre­determined path selected.
  • the sample liquid thus ultimately reaches the reaction site not by lateral flow from the sample receiving site, but rather by traversing the sample receiving site in or on the top member in a transverse flow into the second member and up into the top member.
  • the reaction site is placed on the top member. It may be placed at the bottom member under appropriate circumstances.
  • the characteristics of the members can be varied in such a way as to create either a rapid pulling action from the top member and/or a pumping action due to differential wicking characteristics between the lower member and the top member.
  • Sample flow in the second member which receives the sample from the sample receiving site is also restricted by barrier means which constrain the flow of liquid in the second member to a defined space and a direction of that flow up into the first member.
  • the analyte of the sample dropped onto a top member in a manner in which the sample is prevented from flowing laterally to any substantial degree across the top member but is constrained to flow transversely can be ultimately transferred to a reaction site located on the top member.
  • This reaction site (whether located on the top member or on the bottom member) may either have reagents deposited thereon or may be itself a receiving site for additional reagents either directly applied or directed through the same route as the original sample deposition.
  • the present invention requires the placement of a defined sample receiving site juxtaposed with certain liquid flow barriers and a reaction site in a pre-determined fashion so as to direct the flow of the sample liquid in the pre-selected fashion.
  • the members themselves may be either hydrophilic or hydrophobic depending on the test characteristics and the analytes to be tested.
  • analyses of aqueous or non-aqueous samples may be performed.
  • Non-aqueous samples containing organic solvent-based material may be employed with hydrophobic members in appropriate circumstances.
  • the invention also permits the use of hydrophobic material with aqueous samples should personal preferences dictate.
  • hydrophobic materials are glass fiber, certain nylons, teflon, and polyvinyl chloride polymers.
  • hydrophilic materials are paper, certain cellulose acetates, polyvinylidene difluoride, cellulose nitrate, polypropylene, certain microfiber­glass compositions and the like.
  • a combination of members with different porosities and binding characteristics with the added capability of being either hydrophilic or hydrophobic provides in the device a) the ability to perform on both aqueous and nonaqueous samples, b) the binding of reactants on one or both of the members and at different sites in the flow path of sample or reagents, and c) through impermeable barriers or slots, the ability to differentially control flow rates.
  • the sample is added to the sample port to hydrate a reactant in the bottom or lower member.
  • the reactant may be a competing analyte bound to an indicator such as enzyme or colloidal gold.
  • a binding (capture) antibody is in this case, located at the reaction site.
  • the member may be protein-binding, if desired to retain the capture antibody.
  • the lower member could be non-protein-binding in the region of the placement of the indicator conjugate but could be protein-binding at the terminus past the reaction site to retain reactants and prevent them from diffusing back to the reaction site.
  • the bottom member could be initially protein binding and during manufacture have adhered thereto one or more enzymes for an assay to determine the presence of a substrate in a sample solution.
  • the sample would move through the lower member contacting specific enzymes in a determined sequential manner to effect the production of a product which could then be observed at the reaction site.
  • immunoassay procedures can be performed on the device. These include but are not limited to competitive assays for small analytes, sandwich assays, and direct detection of reactants in samples. It will also be obvious that other non-­immunologically based assays, such as substrate and product detection, use of nucleic acid probes, lectins, or any other ligand-receptor pairs with various indicator systems can be performed on the device as well.
  • the liquid when a liquid sample is applied to the sample site in or on the upper member, the liquid will wick by capillary action into the lower member in either a rapid fashion or slower fashion depending upon the characteristics of the member selected. It is preferred under certain circumstances that the lower member have a pore size substantially larger than the pore size of the upper member to facilitate a pumping action on the return flow from the bottom member to the top member.
  • Sample is prevented from moving laterally from the sample receiving site because the edge of the sample site has been rendered impermeable by the installed barrier means.
  • barrier means may be compression sites, slots, discontinuities in the material, sonic or heat-generated barriers and the like and are all within the skill of the art to construct and place.
  • reaction site may contain the elements of an indicator system useful in detecting the analyte (or substrate) of interest.
  • the reaction site may be located in the lower member with the top member serving as the remote site for accumulation of reactants and sample past the reaction site.
  • the reaction site may conveniently contain antibodies (capture antibodies) to the analyte of interest, which said antibodies are covalently bonded or otherwise attached to the upper member.
  • a protein-binding type of member may be selected as the top member to facilitate the binding of the antibody.
  • a conjugate of an indicator molecule attached to the analyte of interest is selected.
  • a preferred conjugate is the analyte bound directly to colloidal gold if feasible, or to a carrier molecule if, for example, the analyte is unable or poorly able to bind to the gold itself.
  • Colloidal gold is a well-known reagent used in diagnostic procedures because of its characteristic reddish color.
  • carrier molecules there may be employed for example, natural or synthetic proteins or other macromolecules such as BSA, poly L-Lysine, polysaccharides, histones, casein, horse­radish peroxidase and the like.
  • the conjugate may be admixed with the sample prior to applying the sample to the receiving site or may be installed in the device somewhere in the pre­determined liquid flow path prior to the reaction site. If the analyte in the sample is homologous to the analyte adhered to the colloidal gold, it will compete with the analyte-gold conjugate at the reaction site for the capture antibody.
  • the analyte-gold conjugate will lose in the competition to the analyte in the sample, and no conjugate will remain bound to the capture antibody.
  • the reaction can then be traced by the absence of the accumulation of gold at the reaction site.
  • a positive reaction is signified by a lack of change of color at the reaction site (i.e., absence of conjugate).
  • This reaction normally termed a competitive binding assay, is typical of the ones that may be performed with the device of the present invention. Other formats may be used as well as will be described hereinafter.
  • Figure 1 is a cross-sectional view taken across the plane A-­A of Figure 2 of a device of the present invention.
  • Figure 2 is an embodiment of the device of the invention shown in circular form.
  • Figure 3 is a device of the invention shown after it has been acted upon by a test liquid operating on the device of Figure 1.
  • Figure 4 is a top view of another embodiment of a device of the present invention.
  • Figure 1 shows a device of the present invention at 10 wherein a bilayered device is shown with two of the four reaction sites 15 shown in the plane of dissection A-A of Figure 2.
  • Upper layer 20 is provided with a sample port 16 and vent ports 19, and communicates with member 11 at interface 14.
  • Bounding sample port 16 are barriers 13.
  • Member 20 and member 11 may be the same or different material and may have the same or different porosities and/or the same or different wicking actions.
  • the bottom layer has a pore size about 5 to 10 times greater than the pore size of the upper member and the pore size of the upper member is in the range of 0.2-0.75 microns.
  • the larger pore size should not be so large as to provide a sink for the liquid, since this will frustrate the pumping action desired. What is highly desirable however is a pore size that results in a "push" of the sample through the sample port into the lower member followed by a “pull” (as will be described later) of the liquid from the lower member back into the first member.
  • Members 11 and 20 are also equipped with barriers 13a and 13b which are generally incorporated during the manufacturing process as by welding or by incorporation of slots, discontinuities or the like. Barriers 13b are incorporated to provide additional reservoir compartments and are optional depending on the size of the reservoir desired. Barriers 13c are also optional; in practice, the barrier at 13 is usually sufficient. There may be some circumstances, however, where the kinetics of the test and the device size are such that it would be desirable to direct the upward flow of liquid into the top member at a point somewhat remote from the sample receiving site. In such a case, barriers 13c may be provided and interface 14a rendered impermeable or not, as desired.
  • reaction sites 15 containing various reactants placed in accordance with and in consideration of the ultimate test that is to be performed. As shown in Figure 2, these reaction sites may be more than one in number and may be for the same or different analytes coming from the same sample or may be for a control.
  • the device 10 may also have either antibodies or antigens, but preferably in the discussion given herein, will have antibody 17 attached to the member 10 either by covalent bonding or some other physical or chemical attachment.
  • member 11 there is also provided in member 11, at 18, a conjugate shown as Au ⁇ of colloidal gold or some other indicator system conjugated to an antigen which is specific for or will react with the antibody at 17.
  • conjugate 18 of the gold (or other indicator system) to the antigen incorporated into the flow path of the device prior to the reaction site 15.
  • conjugate may be admixed with sample instead of being incorporated into the device, and the sample/conjugate mixture be allowed to follow the flow path to reaction site 15.
  • any other detection systems used in immunoassays such as enzymes, fluorescing agents, latex beads, luciferases, chemilumniscent agents and the like depending upon the best mode of reaction for the given analyte as determined by individual preferences.
  • a liquid sample is dropped into sample port 16 and the sample allowed to diffuse into member 11 and mix with conjugate 18. Lateral flow is prevented by the barriers 13 which direct flow of the sample into the second member. Upon reaching the second member, the liquid is directed laterally until it reaches a barrier (e.g. 13a) or until it is not permitted to go any further and is "pulled” into member 20 in admixture with conjugate 18. The mixture then migrates to the reaction site 15. At the reaction site 15, if the sample contains analyte corresponding to the antigen which is conjugated to the indicator system, it will compete with the conjugate in reaction with antibody 17. If the sample contains no such antigen, then the only reactant at site 15 other than antibody 17 will be conjugate which will then react and show a color change.
  • a barrier e.g. 13a
  • reaction device as shown in Figure 4 for example, is equipped with viewing ports so that the migration of the gold or indicator system away from the reaction site 15 is obscured, then a change in color at the reaction site 15 is all that one needs to observe.
  • Sufficient wash material or sample may be applied to permit the visualization of the clear spot in the event that sample does contain the suspected analyte.
  • Figure 2 has been shown as being circular in form, it may be of any convenient shape such as rectangular, cross-­shaped or the like. In addition, it need not be restricted to one reaction site or sample receiving port but may include a variety and a plurality of either or both of those and may include reactants for detection of various analytes.
  • polyvinylidene difluoride with pore sizes of about 0.2 to 0.75 microns for the top member and from 3-5 microns for the lower member.
  • Various other materials may be employed such as cellulose acetates, cellulose nitrates, polypropylenes, certain microglass fiber compositions and the like.
  • the present invention is also suitable for a competitive assay in which the analyte is an antibody to be determined instead of an antigen.
  • the present invention is also suitable for the detection of an antigen or antibody as an analyte wherein a sandwich technique is employed for the reaction.
  • hCG human chorionic gonadotropin
  • gold conjugated to anti-beta hCG is placed in the bottom member at 18 ( Figure 1) and anti-­alpha hCG (capture Ab) is covalently or otherwise attached to the upper member at 15.
  • sample contains hCG it binds to the gold/antibody conjugate and migrates to site 15 where the sample hCG part of the complex binds to the capture antibody (17) and yields a red color at site 15 indicating a positive result.
  • the gold-anti-beta hCG complex has no hCG bound to it. The complex would not bind to capture antibody 17 but would instead migrate past the reaction site to the remote reaches of member 20 and/or member 11 (e.g. to 12 on member 20).

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
EP19900301907 1990-02-21 1990-02-22 Dispositif multicouche pour tests de diagnostic en vue de la détermination de substances dans des liquides Expired - Lifetime EP0443231B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CA002010569A CA2010569A1 (fr) 1990-02-21 1990-02-21 Carte de detection multicouche pour determiner la presence de matieres solides dans les produits liquides
DE1990623476 DE69023476T2 (de) 1990-02-22 1990-02-22 Mehrschicht-Testvorrichtung zur Bestimmung von Substanzen in Flüssigkeiten.
ES90301907T ES2081924T3 (es) 1990-02-22 1990-02-22 Dispositivo de ensayo de diagnostico de capas multiples para determinar la presencia de sustancias en medios liquidos.
EP19900301907 EP0443231B1 (fr) 1990-02-22 1990-02-22 Dispositif multicouche pour tests de diagnostic en vue de la détermination de substances dans des liquides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP19900301907 EP0443231B1 (fr) 1990-02-22 1990-02-22 Dispositif multicouche pour tests de diagnostic en vue de la détermination de substances dans des liquides

Publications (2)

Publication Number Publication Date
EP0443231A1 true EP0443231A1 (fr) 1991-08-28
EP0443231B1 EP0443231B1 (fr) 1995-11-08

Family

ID=8205304

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900301907 Expired - Lifetime EP0443231B1 (fr) 1990-02-21 1990-02-22 Dispositif multicouche pour tests de diagnostic en vue de la détermination de substances dans des liquides

Country Status (3)

Country Link
EP (1) EP0443231B1 (fr)
DE (1) DE69023476T2 (fr)
ES (1) ES2081924T3 (fr)

Cited By (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571940A1 (fr) * 1992-05-29 1993-12-01 Roche Diagnostics GmbH Support d'essai pour la détection d'analyte et procédé de fabrication dudit support
EP0571941A1 (fr) * 1992-05-29 1993-12-01 Roche Diagnostics GmbH Support d'essai contenant d'un non-tisse
EP0621478A1 (fr) * 1993-04-20 1994-10-26 Fuji Photo Film Co., Ltd. Support à film analytique sec
US5736188A (en) * 1994-08-08 1998-04-07 Alcock; Susan Printed fluid transport devices
WO2000042430A1 (fr) * 1999-01-15 2000-07-20 Medtox Scientific, Inc. Bande de test a ecoulement lateral
WO2001073395A3 (fr) * 2000-03-27 2002-07-18 Usf Filtration & Separations Procede empechant le prelevement bref par un dispositif se remplissant par capillarite ou par effet de meche
FR2826454A1 (fr) * 2001-06-26 2002-12-27 Bio Merieux Cartes d'analyse
US6612111B1 (en) 2000-03-27 2003-09-02 Lifescan, Inc. Method and device for sampling and analyzing interstitial fluid and whole blood samples
EP1275963A3 (fr) * 2001-07-09 2004-11-17 Bayer Corporation Dispositif permettant d'effectuer des tests sur un volumètre
US7604775B2 (en) 2002-08-12 2009-10-20 Bayer Healthcare Llc Fluid collecting and monitoring device
US8153081B2 (en) 2003-05-29 2012-04-10 Bayer Healthcare Llc Test sensor and method for manufacturing the same
WO2017209688A1 (fr) * 2016-05-31 2017-12-07 Cell Id Pte Ltd Trousse d'analyse

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5877028A (en) 1991-05-29 1999-03-02 Smithkline Diagnostics, Inc. Immunochromatographic assay device
US5607863A (en) 1991-05-29 1997-03-04 Smithkline Diagnostics, Inc. Barrier-controlled assay device
US5998220A (en) 1991-05-29 1999-12-07 Beckman Coulter, Inc. Opposable-element assay devices, kits, and methods employing them
US5869345A (en) 1991-05-29 1999-02-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing conductive barrier
US5468648A (en) 1991-05-29 1995-11-21 Smithkline Diagnostics, Inc. Interrupted-flow assay device
US5879951A (en) 1997-01-29 1999-03-09 Smithkline Diagnostics, Inc. Opposable-element assay device employing unidirectional flow
US5939252A (en) 1997-05-09 1999-08-17 Lennon; Donald J. Detachable-element assay device

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0034049A1 (fr) * 1980-02-06 1981-08-19 EASTMAN KODAK COMPANY (a New Jersey corporation) Dispositif d'essai pour l'analyse d'une pluralité de constituants
EP0066648A1 (fr) * 1981-06-05 1982-12-15 Fuji Photo Film Co., Ltd. Element d'analyse à plusieurs couches utilisant une réaction de liaison spécifique
EP0097952A2 (fr) * 1982-06-30 1984-01-11 Fuji Photo Film Co., Ltd. Elément d'analyse à couches multiples
EP0345781B1 (fr) * 1988-06-09 1995-08-30 Boehringer Mannheim Corporation Un dispositif d'essai ayant un volume déterminé

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0034049A1 (fr) * 1980-02-06 1981-08-19 EASTMAN KODAK COMPANY (a New Jersey corporation) Dispositif d'essai pour l'analyse d'une pluralité de constituants
EP0066648A1 (fr) * 1981-06-05 1982-12-15 Fuji Photo Film Co., Ltd. Element d'analyse à plusieurs couches utilisant une réaction de liaison spécifique
EP0097952A2 (fr) * 1982-06-30 1984-01-11 Fuji Photo Film Co., Ltd. Elément d'analyse à couches multiples
EP0345781B1 (fr) * 1988-06-09 1995-08-30 Boehringer Mannheim Corporation Un dispositif d'essai ayant un volume déterminé

Cited By (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0571941A1 (fr) * 1992-05-29 1993-12-01 Roche Diagnostics GmbH Support d'essai contenant d'un non-tisse
US5451350A (en) * 1992-05-29 1995-09-19 Boehringer Mannheim Gmbh Test carrier for the determination of an analyte as well as a process for its production
US5478752A (en) * 1992-05-29 1995-12-26 Boehringer Mannheim Gmbh Analytical method and device containing a fleece layer
EP0571940A1 (fr) * 1992-05-29 1993-12-01 Roche Diagnostics GmbH Support d'essai pour la détection d'analyte et procédé de fabrication dudit support
EP0621478A1 (fr) * 1993-04-20 1994-10-26 Fuji Photo Film Co., Ltd. Support à film analytique sec
US5935520A (en) * 1993-04-20 1999-08-10 Fuji Photo Film Co., Ltd. Dry analytical element
US5736188A (en) * 1994-08-08 1998-04-07 Alcock; Susan Printed fluid transport devices
US6566051B1 (en) 1999-01-15 2003-05-20 Medtox Scientific, Inc. Lateral flow test strip
WO2000042430A1 (fr) * 1999-01-15 2000-07-20 Medtox Scientific, Inc. Bande de test a ecoulement lateral
US6612111B1 (en) 2000-03-27 2003-09-02 Lifescan, Inc. Method and device for sampling and analyzing interstitial fluid and whole blood samples
US7131342B2 (en) 2000-03-27 2006-11-07 Lifescan, Inc. Method of preventing short sampling of a capillary or wicking fill device
WO2001073395A3 (fr) * 2000-03-27 2002-07-18 Usf Filtration & Separations Procede empechant le prelevement bref par un dispositif se remplissant par capillarite ou par effet de meche
US6823750B2 (en) 2000-03-27 2004-11-30 Lifescan, Inc. Method of preventing short sampling of a capillary or wicking fill device
AU2001249468B2 (en) * 2000-03-27 2005-09-29 Lifescan, Inc. Method of preventing short sampling of a capillary or wicking fill device
RU2264861C2 (ru) * 2000-03-27 2005-11-27 Лайфскен, Инк. Способ предотвращения кратковременного взятия проб устройством, заполняемым действием капиллярной силы или капиллярным затеканием
FR2826454A1 (fr) * 2001-06-26 2002-12-27 Bio Merieux Cartes d'analyse
WO2003000748A1 (fr) * 2001-06-26 2003-01-03 bioMérieux Cartes d'analyse
EP1275963A3 (fr) * 2001-07-09 2004-11-17 Bayer Corporation Dispositif permettant d'effectuer des tests sur un volumètre
AU785113B2 (en) * 2001-07-09 2006-09-21 Bayer Healthcare Llc Volume meter testing device
US7776608B2 (en) 2001-07-09 2010-08-17 Bayer Healthcare Llc Volume meter testing device and method of use
US7604775B2 (en) 2002-08-12 2009-10-20 Bayer Healthcare Llc Fluid collecting and monitoring device
US8153081B2 (en) 2003-05-29 2012-04-10 Bayer Healthcare Llc Test sensor and method for manufacturing the same
US8506903B2 (en) 2003-05-29 2013-08-13 Bayer Healthcare Llc Test sensor and method for manufacturing the same
WO2017209688A1 (fr) * 2016-05-31 2017-12-07 Cell Id Pte Ltd Trousse d'analyse

Also Published As

Publication number Publication date
ES2081924T3 (es) 1996-03-16
DE69023476D1 (de) 1995-12-14
DE69023476T2 (de) 1996-03-21
EP0443231B1 (fr) 1995-11-08

Similar Documents

Publication Publication Date Title
US5202268A (en) Multi-layered test card for the determination of substances in liquids
EP0443231B1 (fr) Dispositif multicouche pour tests de diagnostic en vue de la détermination de substances dans des liquides
US7569397B2 (en) Immunoassay devices and use thereof
AU2001253354B9 (en) Diagnostic device with multiple independent flow paths
EP0987550B1 (fr) Dispositif analytique et méthode d'utilisation
EP0447154B1 (fr) Moyen pour des méthodes ligands-récepteurs
US5759866A (en) Device and method for assaying biological components in sample
US20110229913A1 (en) Method for Amplification of Signal in Immunochromatographic Assay and Immunochromatographic Kit Using the Method
US20110091906A1 (en) Immuno gold lateral flow assay
US20120208299A1 (en) Reduced Step Dual Path Immunoassay Device and Method
CA2460072C (fr) Dispositif de test multi-analytes a zone de detection multipoints
JPH08501627A (ja) 自己確認効力検定装置
WO2007055712A1 (fr) Essai d’écoulement latéral immuno-or
US20030073121A1 (en) Multi-analyte assay device with multi-spot detection zone
AU2002334550A1 (en) Multi-analyte assay device with multi-spot detection zone
JP2010032396A (ja) バイオセンサ
KR20220047198A (ko) 면역크로마토그래피용 스트립, 키트 및 이를 이용하여 트립타제를 측정하는 샌드위치 면역크로마토그래피 분석 방법
JP2006038700A (ja) 分析装置及び分析方法
JP2009192222A (ja) 免疫学的測定方法
US20050221386A1 (en) Chromatographic exclusion agglutination assay and methods of use thereof
CA2010569A1 (fr) Carte de detection multicouche pour determiner la presence de matieres solides dans les produits liquides
JPH03276067A (ja) 液中物質測定用複合デバイス
CN100390542C (zh) 特异结合分析方法和使用该方法的装置
US20070042504A1 (en) Method for determining substance or substances in liquid sample
WO1992018869A1 (fr) Dispositif de reference a coloration rapide pour dosages immunologiques

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): BE DE ES FR GB IT LU NL SE

17P Request for examination filed

Effective date: 19920228

17Q First examination report despatched

Effective date: 19931220

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: EDITEK, INC.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): BE DE ES FR GB IT LU NL SE

REF Corresponds to:

Ref document number: 69023476

Country of ref document: DE

Date of ref document: 19951214

ITF It: translation for a ep patent filed
ET Fr: translation filed
REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2081924

Country of ref document: ES

Kind code of ref document: T3

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20050222

PGRI Patent reinstated in contracting state [announced from national office to epo]

Ref country code: IT

Effective date: 20080301

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20090317

Year of fee payment: 20

Ref country code: LU

Payment date: 20090303

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20090219

Year of fee payment: 20

Ref country code: NL

Payment date: 20090203

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20090217

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20090225

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: SE

Payment date: 20090206

Year of fee payment: 20

Ref country code: IT

Payment date: 20090218

Year of fee payment: 20

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20090213

Year of fee payment: 20

BE20 Be: patent expired

Owner name: *EDITEK INC.

Effective date: 20100222

REG Reference to a national code

Ref country code: GB

Ref legal event code: PE20

Expiry date: 20100221

Ref country code: NL

Ref legal event code: V4

Effective date: 20100222

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20100223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20100221

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20100222

Ref country code: ES

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20100223

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF EXPIRATION OF PROTECTION

Effective date: 20100222